| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 10, 2002
From the Division of Cardiovascular Medicine (Y.O., M.T., S.U., U.I., K.S.), Department of Medicine; the Divisions of Organ Replacement Research (M.T., E.K.), Functional Genomes (S.U., H.M.), and Genetic Therapeutics (T.O., K.O.), Center for Molecular Medicine; and the Department of Anatomy (K.T., S.O.), Jichi Medical School, Tochigi, Japan, and the Center for Cardiovascular Research (B.C.B.), University of Rochester, Rochester, NY. * To whom correspondence should be addressed. E-mail: masafumi{at}jichi.ac.jp.
Abstract--Apoptosis of cardiac myocytes is thought to be a feature of many pathological disorders, including congestive heart failure (CHF) and ischemic heart disease (IHD). Because recent investigations indicate that endothelin-1 (ET-1) plays an important role in CHF and IHD, we investigated the effect of ET-1 on cardiomyocyte apoptosis. The presence of apoptosis in rat cardiomyocytes (H9c2 and neonatal) was evaluated by morphological criteria, electrophoresis of DNA fragments, 4',6'-diamidine-2'-phenylindole staining, and TUNEL analysis. ET-1, but not angiotensin II, prevented apoptosis induced by serum deprivation via ETA receptors in a dose-dependent manner (1 to 100 nmol/L). ET-1 also prevented cytochrome c release from mitochondria to the cytosol. The use of specific pharmacological inhibitors demonstrated that the antiapoptotic effect of ET-1 was mediated through a tyrosine kinase pathway (genistein and AG490) but not through protein kinase C (PKC; calphostin C), mitogen-activated protein kinases (PD98059 and SB203580), or PKA (KT5270) pathways. Adenovirus-mediated gene transfer of kinase-inactive (KI) c-Src reversed the antiapoptotic effect of ET-1. We further investigated whether Bcl-xL, an antiapoptotic molecule, would be upregulated by using a luciferase-based reporter system. ET-1 upregulated Bcl-xL, and this upregulation was inhibited by genistein or AG490 but not by calphostin C. The experiments with KI mutants for various tyrosine kinases revealed that c-Src and Pyk2 (but not JAK1, Jak2, Syk, and Tec) are involved in ET-1-induced upregulation of Bcl-xL expression. These findings suggest that ET-1 prevents apoptosis in cardiac myocytes through the ETA receptor and the subsequent c-Src/Bcl-xL-dependent pathway.
Revised on September 23, 2002
Antiapoptotic Effect of Endothelin-1 in Rat Cardiomyocytes In Vitro
Yukiyo Ogata;
This article has been cited by other articles:
![]() |
D. K. Singla, R. D. Singla, and D. E. McDonald Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H907 - H913. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kang, K. Y. Chung, and J. W. Walker G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart Physiology, June 1, 2007; 22(3): 174 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. McWhinnie, D. V. Pechkovsky, D. Zhou, D. Lane, A. J. Halayko, D. A. Knight, and T. R. Bai Endothelin-1 induces hypertrophy and inhibits apoptosis in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L278 - L286. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-N. Raymond, C. Bole-Feysot, Y. Banno, Z. Tanfin, and P. Robin Endothelin-1 Inhibits Apoptosis through a Sphingosine Kinase 1-Dependent Mechanism in Uterine Leiomyoma ELT3 Cells Endocrinology, December 1, 2006; 147(12): 5873 - 5882. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, G. Yan, A. Ren, B. You, and J. K. Liao FHL2/SLIM3 Decreases Cardiomyocyte Survival by Inhibitory Interaction With Sphingosine Kinase-1 Circ. Res., September 1, 2006; 99(5): 468 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-S. Zhao, W. Pan, R. Bekeredjian, and R. V. Shohet Endogenous Endothelin-1 Is Required for Cardiomyocyte Survival In Vivo Circulation, August 22, 2006; 114(8): 830 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shimojo, S. Jesmin, S. Zaedi, M. Soma, S. Maeda, I. Yamaguchi, K. Goto, and T. Miyauchi Changes in important apoptosis-related molecules in the endothelin-1-induced hypertrophied cardiomyocytes: effect of the pretreatment with eicosapentaenoic Acid. Experimental Biology and Medicine, June 1, 2006; 231(6): 932 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Marrero, A. K. Banes-Berceli, D. M. Stern, and D. C. Eaton Role of the JAK/STAT signaling pathway in diabetic nephropathy Am J Physiol Renal Physiol, April 1, 2006; 290(4): F762 - F768. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masaki, M. Izumi, Y. Oshima, Y. Nakaoka, T. Kuroda, R. Kimura, S. Sugiyama, K. Terai, M. Kitakaze, K. Yamauchi-Takihara, et al. Smad1 Protects Cardiomyocytes From Ischemia-Reperfusion Injury Circulation, May 31, 2005; 111(21): 2752 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Casey, P. G. Arthur, and M. A. Bogoyevitch Proteomic Analysis Reveals Different Protein Changes during Endothelin-1- or Leukemic Inhibitory Factor-induced Hypertrophy of Cardiomyocytes in Vitro Mol. Cell. Proteomics, May 1, 2005; 4(5): 651 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Melendez, C. Turner, H. Avraham, S. F. Steinberg, E. Schaefer, and M. A. Sussman Cardiomyocyte Apoptosis Triggered by RAFTK/pyk2 via Src Kinase Is Antagonized by Paxillin J. Biol. Chem., December 17, 2004; 279(51): 53516 - 53523. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tokudome, T. Horio, M. Fukunaga, H. Okumura, J. Hino, K. Mori, F. Yoshihara, S.-I. Suga, Y. Kawano, M. Kohno, et al. Ventricular Nonmyocytes Inhibit Doxorubicin-Induced Myocyte Apoptosis: Involvement of Endogenous Endothelin-1 as a Paracrine Factor Endocrinology, May 1, 2004; 145(5): 2458 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Aoki, N. L. Guinazu, A. V. Pellegrini, T. Gotoh, D. T. Masih, and S. Gea Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes Am J Physiol Cell Physiol, February 1, 2004; 286(2): C206 - C212. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |